That's more like it! A clear statement that Dr Feldman is currently working on the parameters of the Phase3 trial and they are having success throughout phase2 is just what I needed to calm my nerves about this horrific drop. I know I could have expected it due to the market and lack of any real PR from last weeks talks but I am now reassured.